Sign in
8-K

Current Report

Protalix BioTherapeutics, Inc. Filed Acc 0001104659-26-000393

Regulation FD disclosure

  • Item 7.01 Regulation FD disclosure

From the SEC's structured data for this filing

Loading plx-20260105x8k.htm…